<DOC>
	<DOCNO>NCT02588144</DOCNO>
	<brief_summary>54 patient idiopathic Parkinson 's disease freeze gait resistant subthalamic nucleus stimulation dopaminergic medication include multicentre randomise control double-blinded parallel group clinical trial . The treatment consist two different stimulation setting use ( ) conventional stimulation subthalamic nucleus [ standard STN ] active comparator ( ii ) combine stimulation active electrode contact locate subthalamic nucleus substantia nigra par reticulata [ STN+SNr ] .</brief_summary>
	<brief_title>Combined Stimulation STN SNr Resistant Freezing Gait Parkinson 's Disease</brief_title>
	<detailed_description>The primary endpoint study investigate efficacy safety combine [ STN+SNr ] stimulation `` interleaving stimulation '' compare [ standardSTN ] 3 month refractory freeze gait ( FOG ) . The Trial design superiority study 80 % power detect mean improvement 4.7 point Freezing Gait Assessment Course ( Ziegler et al. , 2010 ) one-tailed P &lt; 0.2 . To end 54 patient study . After common baseline assessment [ standardSTN ] , patient randomize either [ standardSTN ] [ STN+SNr ] 1:1 ratio ( 27 per arm ) . The primary endpoint assessment schedule 90 day baseline assessment ( V6 ) . Additional interim visit schedule secondary purpose baseline day 2 ( V2 ) , day 8 ( V3 ) , day 21 ( V4 ) , day 42 ( V5 ) . The rationale study come previous phase II trial ( Weiss et al. , 2013 ) observe improvement freeze gait combine STN+SNr stimulation secondary endpoint compare standard STN stimulation three-week follow-up . Secondary outcome measure include anamnestic assessment freeze gait fall , balance , quality life , neuropsychiatric symptom suicidality .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Idiopathic Parkinson 's disease ( accord `` British Brain Bank criterion '' ( Hughes , 1992 ) include genetic form Therapy STNDBS ( deep brain stimulation ) ( ACTIVA pulse generator ) least six month surgery Activa PC ( Primary Cell ) Activa RC ( Rechargeable Cell ) implant pulse generator `` Interleaving '' program option Localization active electrode contact subthalamic nucleus Localization caudal electrode contact substantia nigra par reticulata area ( coordinate relative midcommisural Point ( MCP ) : leave : 7mm ≤ x ≤ 12mm ; 2mm ≤ ≤ 6mm ; 6mm ≤ z ≤ 10mm right : 7mm ≤ x ≤ 12mm ; 2mm ≤ ≤ 6mm ; 6mm ≤ z ≤ 10mm ( x = mediolateral , = anterioposterior , z = rostrocaudal ) ≥ 30 % improvement UPDRS III 'standard STN ' compare 'stimulation ' dopaminergic Freezing Gait Assessment Course ≥10 ≤33 Patient wheelchairbound possible move selfdependently outside freeze episode . Disease duration ≥ 5 year Age : 18 80 year Dopaminergic medication constant least four week prior study enrolment Written inform consent Participation clinical trial within past three month enrolment study Cognitive impairment ( Mini Mental State Exam &lt; 20 ) Suicidality , Psychosis Other severe pathological chronic condition might confound treatment effect interpretation data Pregnancy Paradoxical levodopainduced `` '' state freezing ( Espay et al. , 2012 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>freeze gait</keyword>
	<keyword>deep brain stimulation</keyword>
	<keyword>substantia nigra par reticulata</keyword>
	<keyword>subthalamic nucleus</keyword>
</DOC>